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Effect of low-dosage vitamin A and riboflavin on iron-folate 
supplementation in anaemic pregnant women
Bambang Suprapto, MD, MMedicalSci, RNutr, Widardo, BSc, MSc and Suhanantyo BSc
Department of Nutrition, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
A double-blind, placebo, controlled trial was conducted in Banyudono subdistrict, Boyolali regency, Central
Java province, Indonesia. The aim of the study was to determine whether adding low-dosage vitamin A and
riboflavin can enhance the effect of iron-folate supplementation in anaemic pregnant women. From July to
November 2000, 202 pregnant women were screened for anaemia (haemoglobin <11.0 g/dL). One hundred and
three pregnant women (51%) were found to be anaemic and were then allocated alternately into four groups.
Over a period of 60 days, group IF (n = 29) received iron-folate tablets (200 mg FeSO4 and 250 µg folic
acid) + 5 mg glucose; group IFR (n = 22) received iron-folate tablets + 5 mg riboflavin; group IFA (n = 29)
received iron-folate tablets + 2.75 mg retinyl palmitate (equal to 5000 IU vitamin A); and group IFRA (n = 23)
received iron-folate tablets + 5 mg riboflavin + 2.75 mg retinyl palmitate. At the end of the study 19 pregnant
women (18.4%) were excluded from the analysis because of various reasons. Statistical analysis was based on
84 women (81.5%): group IF, n = 25; group IFR, n = 22; group IFA, n = 18; and group IFRA, n = 19.
Haemoglobin measurements were carried out using the Technicon H1* (cyanmethaemoglobin method). All
groups showed a significant increase in haemoglobin concentration (P < 0.05), except group IFA (P > 0.05),
with the highest increment being in group IFR. Multiple comparisons only showed significant differences
between group IFR and group IFA (P < 0.05). It can be concluded that iron-folate supplementation can increase
haemoglobin concentrations in anaemic pregnant women. Adding riboflavin tends to enhance the effect of iron-
folate supplementation, but this is not the case with adding vitamin A.
Key words:  anaemic pregnant women, iron-folate, low-dosage vitamin A, riboflavin.
Introduction
Iron deficiency anaemia (IDA) in pregnant women has
detrimental effects on pregnancy outcome.1 IDA is highly
prevalent among Indonesian pregnant women.2,3 Although
an iron supplementation program for pregnant women has
been provided since 1974, our recent study in the Banyudono
subdistrict, Boyolali regency, Central Java province, Indone-
sia, showed that the prevalence of anaemia among pregnant
women is still very high at around 70% (B Hanim, Suhanan-
tyo, W Atmaka, Padmaningrum, unpubl. data, 1999).4
A recent National Household Health Survey5 (1995)
revealed a substantial reduction in the prevalence of IDA
among pregnant women, from 63.5% in 1992 to 52.4% in
1995. However, it is still considered unacceptably high. The
result of the Mother Care Project evaluation showed that
mass iron-folate supplementation via health centre distribu-
tion was not very effective.6 Low compliance was the main
cause of the failure.7 Nutrient–nutrient interactions may also
affect iron status in pregnant women. In Gambia, Powers
et al. showed that adding riboflavin to iron supplementation
improved haematological parameters in pregnant women.8
Similarly, Suharno et al. showed that adding vitamin A to
iron supplementation increased haemoglobin concentration
in pregnant women in West Java, Indonesia.9
Multiple micronutrient deficiencies are common in
developing countries.10 Our study in Polokarto subdistrict,
Karanganyar regency, Central Java province, Indonesia,
showed a low riboflavin intake among pregnant women.11
Meat and dairy products are rarely consumed in rural areas
of Indonesia. Although Boyolali regency is known as the
‘milk capital’ of Central Java, pregnant women in Banyu-
dono subdistrict rarely consume milk because it is too
expensive for most people in the village. The same is also
true for meat. In East Java, IDA in adult women occurs
together with vitamin A deficiency.12 In Indonesia, high
dosage vitamin A capsules are given only to children under
five years of age and lactating mothers, not to pregnant
women, even though studies show that many pregnant women
are marginally vitamin A deficient.9 The present study exam-
ines the effect of adding riboflavin and low-dosage vitamin A
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to iron-folate supplementation among pregnant women in a
rural area of Indonesia.
Materials and methods
Research setting
The study took place in the rural area of Banyudono sub-
district, Boyolali regency, Central Java province, Indonesia.
This subdistrict is located approximately 100 m above sea
level and 20 km from Solo City. It has 44 000 inhabitants
with two health centres: Banyudono I and Banyudono II.
Banyudono I covers 26 000 inhabitants and Banyudono II
covers 18 000 inhabitants. The population density is
1746 people/km2. Arable agriculture and textiles are the
main sources of income in this area. Boyolali is also known
as the ‘milk capital’ as it is the largest producer of milk for
the canned milk industry in Java. However, no milk is
produced in Banyudono subdistrict itself. The majority of
farmed land comprises paddy fields, with peanuts and
cassava growing in poorly irrigated areas. The area is served
by a network of roads and there are newspapers, electricity,
radio, television, telephone, and post facilities in the area.
Each year there are around 500 new pregnancies in Banyu-
dono subdistrict.
Subjects
In a previous study, we found that animal foods were rarely
consumed by pregnant women in Banyudono subdistrict
because meat and milk were too expensive. It can be
predicted that pregnant women are at risk of riboflavin and
iron deficiency. The main sources of iron and vitamin A are
green leafy vegetables. All pregnant women who visited the
Banyudono health centres’ antenatal clinics from July to
November 2000 were asked to participate in the study. The
inclusion criteria were:
1 Aged less than 35 years. This cut-off was chosen arbit-
rarily as pregnancy complications frequently occur among
older mothers.
2 Weeks of pregnancy between 13 and 28. Due to vitamin A
toxicity to the foetus, we excluded women in the first tri-
mester of pregnancy. The midwife checked the last date of
menstruation and cross-checked with the size of the
uterus.
3 Single pregnancy.
4 Apparently in good health and checked by the doctor at
the antenatal clinic. Pregnant women with pre-eclampsia,
congestive heart disease, tuberculosis and acute infections
were excluded from the study.
5 Agree to participate in the study.
Of the 202 pregnant women screened, 103 were anaemic
(Haemoglobin <11 g/dL), corresponding to 51% of the sub-
jects. All pregnant women were numbered and listed. They
were then allocated alternately into groups according to
their numbers. Group IF (n = 29) received iron-folate
tablets + 5 mg glucose (placebo); group IFR (n = 22)
received iron-folate tablets + 5 mg riboflavin; group IFA
(n = 29) received iron-folate tablets + 2.75 mg retinyl palmi-
tate (equal to 5000 IU vitamin A); and group IFRA (n = 23)
received iron-folate tablets + 5 mg riboflavin + 2.75 mg
retinyl palmitate. These were administered seven days a
week for 60 days. All supplements had the same colour,
shape and size in capsule form and were given in a double-
blind manner. To ensure compliance, two midwives visited
the subjects at their home every week and checked the
capsules consumed. Neither the midwives nor the research-
ers knew which capsules they had given to the subjects. Only
the Head of the Health Centre kept the list and opened it at
the end of the study, just before the analysis.
Study protocol
A trained laboratory assistant took the blood samples.
Venous blood samples were taken from the subjects at
baseline and 60 days later at 08:00–09:00 h. Blood samples
(3 mL) were collected in a vaccutainer containing ethylene-
diaminetetraacetic acid (EDTA) as an anticoagulant and kept
in a cool-box, before being transferred to an accredited
clinical laboratory. Haemoglobin was measured directly.
The remaining blood was centrifuged to separate plasma
from packed cells. The packed cells were then washed with
normal saline and centrifuged. The supernatants were dis-
posed of. An equal volume of aquadest was added to the
washed cells to make the blood haemolysate. The blood
haemolysates were stored frozen at –20°C for measurement
of the erythrocyte glutathione reductase activity coefficient
(EGRAC). Weight, height, mid-upper arm circumference
(MUAC) and dietary intake were recorded at baseline by the
same researcher.
Haemoglobin measurement
Haemoglobin measurements were obtained by analysing
100 µL blood sample in a calibrated Technicon H1*
(Techinicon Instruments, NY, USA) using the cyanmet-
haemoglobin method. Haemogolobin was expressed in g/dL.
Measurement of riboflavin status
Riboflavin status was measured using the assay for erythro-
cyte glutathione reductase (Egr; EC 1.6.4.2) activity as
described by Powers et al.13 EGRAC was measured with a
Cobas Bio Autoanalyser at the Centre for Human Nutrition,
University of Sheffield, UK. For technical reasons, only
blood samples from group IFR were measured. The cut-off
point for riboflavin deficiency is EGRAC <1.4.13
Dietary assessment
An estimated record technique with a 24 h recall was used to
assess dietary intake of the subjects. One of the researchers
undertook the interview and analysed the nutrient intake
using the Food Processor II Software Package (Esha
Research, Salem,. OR, USA) and Comp-Eat (Lifetime Nutri-
tional Services, London, UK) for riboflavin intake.
Anthropometric measurements
Weight was recorded on a calibrated mechanical bathroom
scale to the nearest 0.1 kg (Krups, Ireland) after zeroing for
each measurement. Pregnant women were lightly clothed
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and had removed their footwear. Height was recorded using
a microtoise (Statumeter™, Indonesia) and measured to the
nearest 0.1 cm. Each woman stood with her buttocks, heels
and back against the wall and her head in the Frankfurt
plane. MUAC was measured using a plastic tape to the
nearest 0.1 cm. Data was compared to Indonesian standards
to ascertain nutritional status.
Statistical analysis
Results were expressed as the mean ± standard deviation. To
see the difference between baseline and post-treatment in
each group, a paired t-test was used. For multiple compar-
isons among groups an ANOVA and a least significant differ-
ence test was used. All statistical analysis was performed
using SPSS for Windows, release 10.0 (Chicago, IL, USA).
Ethical considerations
The study was approved by the Central Java Province
Regional Development Board. Subjects were informed about
the nature of the study and agreed to participate in the study.
Results
One hundred and three subjects were recruited initially, but
only 84 (81.5%) were included in the analysis for various
reasons. Nineteen women did not have their second blood
samples taken due to premature labour (nine subjects),
stillbirth (one subject), migration (one subject), refusal to
give blood (one subject), nausea and vomiting (two subjects)
and incorrect dates given for last menstruation but with
normal deliveries (five subjects). Table 1 shows the baseline
characteristics of the subjects. There were no significant
differences in haemoglobin concentration among the groups
at baseline. Of the 84 pregnant women recruited, five
subjects were classified as wasted (4.85%). However, group
IFA and group IFRA had significantly lower weights and
heights (P < 0.05) compared to the other groups. The vast
majority of the subjects were on their first and second
pregnancies. Sixty days after supplementation, haemoglobin
concentration was measured again (Table 2). All groups
showed increased haemoglobin concentrations, except group
IFA (P > 0.05). Table 3 shows the mean differences in
haemoglobin concentration between the groups. Multiple
comparisons only showed significant differences between
group IFR and group IFA (P < 0.05). EGRAC measurement
of group IFR showed low riboflavin status at baseline
(1.82 ± 0.27), which increased significantly after riboflavin
supplementation for 60 days (1.28 ± 0.33; P < 0.001).
Table 4 shows nutrient intakes derived from a 24 h recall.
Group IF showed a higher intake in all selected nutrients
compared with the other groups. In general, the subjects
showed low intakes of iron, riboflavin, protein and energy,
but had high intakes of vitamin C and vitamin A.
Discussion
Iron deficiency anaemia is recognised as a major public
health problem in Indonesia. The Household Health Survey
of 1995 revealed that the prevalence of IDA in pregnant
women is 50.9%.14 The aetiology of IDA is mainly of dietary
origin. Hookworm infestation, malaria and haemoglobino-
pathies are very rare in the study area.15 The government of
Indonesia has set up a target to reduce the prevalence of IDA
to 10% by the year 2018.2 To achieve the target, it is not
Table 2. Haemoglobin concentrations before and after supplementation
Group n Haemoglobin (g/dL) Increment P-value 
Before After
IF 25 10.40 ± 0.54 10.89 ± 0.95 0.492 ± 0.983 0.020*
IFR 22 10.20 ± 0.59 11.02 ± 0.95 0.818 ± 0.673 0.000*
IFA 18 10.39 ± 0.44 10.59 ± 0.93 0.194 ± 0.733 0.276
IFRA 19 10.39 ± 0.41 10.86 ± 0.75 0.463 ± 0.750 0.015*
Values are presented as mean ± SD. *Statistically significant (paired t-test): P < 0.05. IF, iron-folate + 5 mg glucose; IFA, iron-folate + 2.75 mg retinyl palmi-
tate (equivalent to 5000 IU vitamin A); IFR, iron-folate + 5 mg riboflavin; IFRA, iron-folate + 5 mg riboflavin + 2.75 mg retinyl palmitate.









Age (years) 26.63 (5.67) 28.41 (5.59) 25.93 (4.54) 26.14 (6.27)
Weight (kg) 52.60 (3.46) 52.43 (3.22) 50.34 (4.81)* 49.45 (5.16)*
Height (cm) 152.99 (3.46) 154.16 (3.80) 151.79 (4.74)* 150.12 (4.58)*
MUAC (cm) 25.32 (1.52) 24.66 (1.37) 25.12 (1.68) 24.08 (2.54)*
Hb (g/dL) 10.43 (0.50) 10.20 (0.59) 10.41 (0.38) 10.37 (0.43)
Gestation age (week) 21.57 (3.82)* 24.77 (2.86)* 22.83 (6.64) 21.77 (4.53)
No. pregnancies 2.00 (0.91) 2.41 (1.37) 1.86 (1.09) 1.73 (1.16)
Education (year) 9.13 (3.95) 9.59 (4.47) 9.52 (3.41) 10.00 (2.78)
Values are presented as mean ± SD. *Significant at the level of P < 0.05. IF, iron-folate + 5 mg glucose; IFA, iron-folate + 2.75 mg retinyl palmitate (equiva-
lent to 5000 IU vitamin A); IFR, iron-folate + 5 mg riboflavin; IFRA, iron-folate + 5 mg riboflavin + 2.75 mg retinyl palmitate.
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realistic to rely on iron supplementation alone. Although the
government started an iron supplementation program in
1974, IDA prevalence is still unacceptably high at present.
In the case of Java, where rice is the staple and a very
small amount of animal foods is eaten, a little variation was
observed. The main sources of protein, vitamins and miner-
als are green leafy vegetables.11 With such a diet, it can be
predicted that pregnant women in rural areas of Java are at
risk of iron and riboflavin deficiencies. Results of the dietary
recall of the present study confirmed this prediction
(Table 4).
Indonesian recommended dietary allowances (IRDA) for
pregnant women aged 20–45 years with mean weight 54 kg
and height 156 cm17 are as follows: energy, 2485 kCal;
protein, 50 g; vitamin C, 70 mg; vitamin A, 500 retinol
equivalents (RE); iron, 46 mg; riboflavin, 1.4 mg; and folic
acid, 300 µg. As we did not measure serum retinol, the
vitamin A status of the subjects was unknown. Although we
found that the subjects’ dietary vitamin A intakes exceeded
the IRDA, almost all of it came from plant sources. How-
ever, this probably explains the phenomenon of why adding
vitamin A to group IFA and IFRA did not enhance the effect
of iron supplementation; the subjects were probably not
vitamin A deficient. In addition, the nutritional status of
these groups was lower than the other groups. The vast
majority of the subjects in this study did not meet the IRDA,
especially for iron (10.10–20.84 mg/day) and energy
(1467–2045 kCal/day). This finding indicates that the main
cause of IDA is inadequate dietary iron intake. The intake of
vitamin C (which is good for iron absorption) exceeded the
IRDA, due to consumption of citrus fruits and dark green
leafy vegetables. However, rice-based diets and tea drinking
may reduce its effect.17 The low socioeconomic conditions
of the subjects seemed to exacerbate the problems. A report
by Hellen Keller International in 1998 revealed a reduced
intake of animal foods due to an increase in the prices of
basic commodities and reduced purchasing power of the
population after the economic crisis in Indonesia began in
July 1997.18
Several studies have been carried out on multiple micro-
nutrient supplementation in pregnant women with encourag-
ing results.8–10 Powers et al. showed that adding riboflavin to
iron supplement improved haematological parameters
among pregnant women in Gambia,8 while Suharno et al.
demonstrated a better response with iron + vitamin A than
iron alone in pregnant women in West Java.9
The interrelationship of nutrients affects iron metabo-
lism.8,9,13 According to Powers,20 riboflavin influences iron
metabolism via iron absorption, mobilisation from iron
stores and iron utilisation for haemoglobin synthesis in the
Table 3. Mean differences in haemoglobin concentration after supplementation
Group (I) Group (II) Mean difference (I – II) SE P-value
IF IFR –0.3262 0.2356 0.170
IFA 0.2976 0.2491 0.236
IFRA 0.0288 0.2453 0.907
IFR IF 0.3262 0.2356 0.170
IFA 0.6237* 0.2561 0.017
IFRA 0.3550 0.2524 0.163
IFA IF –0.2976 0.2491 0.236
IFR –0.6237* 0.2561 0.017
IFRA –0.2687 0.2651 0.314
IFRA IF –0.0288 0.2453 0.907
IFR –0.3550 0.2524 0.163
IFA 0.2687 0.2651 0.314
*Significant at the level of P < 0.05. IF, iron-folate + 5 mg glucose; IFA, iron-folate + 2.75 mg retinyl palmitate (equivalent to 5000 IU vitamin A); IFR, iron-
folate + 5 mg riboflavin; IFRA, iron-folate + 5 mg riboflavin + 2.75 mg retinyl palmitate.









Energy (kcal) 2045 ± 445.0* 1749 ± 457.0 1468 ± 349.0 1599 ± 415.0
Protein (g) 66.0 ± 18.1* 48.1 ± 15.2 50.5 ± 16.9 55.8 ± 22.5
Iron (mg) 20.8 ± 5.8* 12.7 ± 4.7 10.1 ± 3.7 13.9 ± 8.8
Vitamin C (mg) 263.4 ± 150.5* 153.9 ± 70.1 126.4 ± 69.1 120.2 ± 70.0
Vitamin A (RE) 1585.7 ± 1333.0* 755.5 ± 422.1 505.5 ± 297.0 1208.5 ± 1172.6
Vitamin B2 (mg) 1.6 ± 1.2* 0.8 ± 0.4 0.5 ± 0.3 0.6 ± 0.4
Values are presented as mean ± SD. *Significant at the level of P < 0.05. IF, iron-folate + 5 mg glucose; IFA, iron-folate + 2.75 mg retinyl palmitate
(equivalent to 5000 IU vitamin A); IFR, iron-folate + 5 mg riboflavin; IFRA, iron-folate + 5 mg riboflavin + 2.75 mg retinyl palmitate; RE, retinal equivalents.
Iron-folate supplementation and pregnancy 267
bone marrow, whereas vitamin A can mobilise iron from its
store. The present study shows significant increases in
haemoglobin concentration in groups IF, IFR and IFRA, but
not in group IFA (Table 2). Although iron-folate supplemen-
tation for 60 days can increase haemoglobin concentration
(group IF), it seems that adding riboflavin tends to enhance
the effect of iron supplementation to a greater degree,
observable for group IFR as the greatest increment in
haemoglobin concentration. The EGRAC measurement
(group IFR only) showed a low riboflavin status at baseline
(1.82 ± 0.27), but increased significantly after riboflavin
supplementation for 60 days (1.28 ± 0.33; P < 0.001). It is
worth noting that those pregnant women (group IFR) at
baseline can be classified as riboflavin deficient
(EGRAC > 1.4) and replenished after supplementation
(EGRAC < 1.4). Riboflavin deficiency is highly prevalent in
developing countries and in developed countries as well.8,20
Riboflavin intake in rural areas of Central Java is low12 due
to low consumption of animal foods and milk. In general, the
subjects in this study had low riboflavin intakes (Table 4).
Therefore, adding riboflavin to iron-folate supplementation
in pregnant women should be considered to enhance its
effect on haemoglobin level. Unexpectedly, however, adding
low-dosage vitamin A (group IFA and group IFRA) did not
enhance the effect of iron-folate supplementation on haemo-
globin level. It is difficult to explain why this happened,
especially because, unfortunately, we did not measure the
vitamin A status of the subjects. However, from dietary
intakes we can speculate that this was because the subjects
were not deficient in vitamin A, or because they had lower
nutritional status, or both (Table 1). It is also difficult to
ensure that the vitamin A capsules were consumed. One can
examine the faeces to check whether iron tablets were
consumed,21 but there are no such measures for vitamin A
supplementation.
In conclusion, the results of this study indicate that
adding riboflavin to iron-folate supplementation tends to
enhance its effect on haemoglobin concentration among
anaemic pregnant women, especially when the subjects are
riboflavin deficient. A further study is needed to clarify
whether adding vitamin A to iron-folate supplementation has
beneficial effects in terms of haemoglobin concentration
among anaemic pregnant women.
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